Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

Published Date: 18 Oct 2024

Odds of undetectable PSA at 48 weeks doubled with addition of Pluvicto

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

2.

New research points out a promising strategy for treating metastatic medulloblastoma

3.

Early palliative care billing up from 2010 to 2019 for advanced cancer

4.

UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts

5.

Healthy weight loss could lower your odds for cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot